Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Share-based Compensation (IS): 2011-2020

  • RedHill Biopharma's Share-based Compensation (IS) changed negligibly% to $1,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $8.3 million, marking a year-over-year decrease of 9.81%. This contributed to the annual value of $665,000 for FY2024, which is 59.62% down from last year.
  • RedHill Biopharma's Share-based Compensation (IS) amounted to $1,000 in Q2 2020, which was down 0.00% from $1,000 recorded in Q2 2019.
  • RedHill Biopharma's 5-year Share-based Compensation (IS) high stood at $5.2 million for Q2 2018, and its period low was $1,000 during Q2 2019.
  • Its 3-year average for Share-based Compensation (IS) is $1.7 million, with a median of $1,000 in 2020.
  • Data for RedHill Biopharma's Share-based Compensation (IS) shows a maximum YoY crashed of 99.98% (in 2019) over the last 5 years.
  • Quarterly analysis of 3 years shows RedHill Biopharma's Share-based Compensation (IS) stood at $5.2 million in 2018, then plummeted by 99.98% to $1,000 in 2019, then remained steady at $1,000 in 2020.
  • Its Share-based Compensation (IS) stands at $1,000 for Q2 2020, versus $1,000 for Q2 2019 and $5.2 million for Q2 2018.